These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. AWP reimbursement scrutinized by several states. Carroll J Manag Care; 2003 Apr; 12(4):11-2. PubMed ID: 12747021 [No Abstract] [Full Text] [Related]
4. Medicines pricing singled out. Buchanan E S Afr Med J; 2004 May; 94(5):334. PubMed ID: 15211941 [No Abstract] [Full Text] [Related]
5. Drug pricing. AHF: Schwarzenegger bows to drug industry donations. AIDS Policy Law; 2005 Oct; 20(19):4. PubMed ID: 16276597 [No Abstract] [Full Text] [Related]
6. Pharmaceutical industry pricing practices: impact of the Bayer settlement. Berkle M Health Care Law Mon; 2001 Jul; ():3-11. PubMed ID: 11484634 [No Abstract] [Full Text] [Related]
7. One lawyer's view of discriminatory pricing. Wentz WH Am Pharm; 1994 Oct; NS34(10):24-7, 42. PubMed ID: 7992788 [No Abstract] [Full Text] [Related]
8. Risks to the 340B Drug Pricing Program Related to Manufacturer Restrictions on Drug Availability. Knox RP; Kesselheim AS; Sarpatwari A JAMA; 2022 May; 327(17):1647-1648. PubMed ID: 35426909 [No Abstract] [Full Text] [Related]
10. Is the "reasonable pricing" clause unreasonable? Jenks S J Natl Cancer Inst; 1994 Oct; 86(19):1445-7. PubMed ID: 8089861 [No Abstract] [Full Text] [Related]
11. Discriminatory pricing lawsuits could change future of community pharmacy. Flanagan ME Am Pharm; 1994 Oct; NS34(10):20-3. PubMed ID: 7992787 [No Abstract] [Full Text] [Related]
12. Drug pricing. AHF sues Abbott over drug price increase. AIDS Policy Law; 2004 Feb; 19(4):2. PubMed ID: 15045981 [No Abstract] [Full Text] [Related]
13. Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology. American Society of Clinical Oncology J Oncol Pract; 2014 Jul; 10(4):259-63. PubMed ID: 24737877 [No Abstract] [Full Text] [Related]
14. Pricing, regulation, and competitiveness. Lessons for the US from the Japanese pharmaceutical industry. Thomas LG Pharmacoeconomics; 1994; 6 Suppl 1():67-70. PubMed ID: 10155588 [TBL] [Abstract][Full Text] [Related]
18. Dealing with drug pricing: not just one solution. The Lancet Lancet; 2019 Dec; 392(10165):2655. PubMed ID: 30587351 [No Abstract] [Full Text] [Related]
19. The Impact of Off-Patent Drug Acquisitions on Prices. Gupta R; Henkel A; Forman HP; Ross JS J Gen Intern Med; 2018 Jul; 33(7):1007-1009. PubMed ID: 29687433 [No Abstract] [Full Text] [Related]
20. US presidential candidates' proposals to reduce drug prices. Jaffe S Lancet; 2016 Aug; 388(10047):855-6. PubMed ID: 27597455 [No Abstract] [Full Text] [Related] [Next] [New Search]